Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this insightful session on understanding the Evolution in Treatment and Diagnosis of Lung Cancer. Manipal Hospitals, a leader in advanced medical care, is proud to present this initiative led by the esteemed Dr. Lalit Sharma. From conventional approaches to groundbreaking targeted therapies and immunotherapies, lung cancer treatment has undergone a significant transformation, offering renewed hope and improved outcomes for patients worldwide. This session aims to delve into these pivotal advancements, highlighting how a comprehensive understanding of evolving diagnostic tools and therapeutic strategies is paramount for delivering personalized and effective patient care.
The landscape of lung cancer management has been revolutionized by innovations in both diagnosis and treatment. Early detection, often facilitated by advanced imaging and novel biopsy techniques, now paves the way for more precise staging and tailored interventions. Furthermore, the advent of molecular profiling, including Next-Generation Sequencing (NGS), allows healthcare providers to identify specific genetic mutations within tumors, such as EGFR, ALK, ROS1, and BRAF. This precision medicine approach enables the selection of targeted therapies that directly address the underlying drivers of cancer, significantly enhancing efficacy and minimizing side effects compared to traditional chemotherapy.
Join us to gain comprehensive knowledge on the latest best practices in the evolution of lung cancer treatment and diagnosis. Dr. Lalit Sharma will share invaluable insights on navigating this rapidly advancing field, empowering medical professionals with the knowledge to optimize patient care and improve survival rates. Listen to this essential webinar, absorb the shared expertise, and continue to follow Hidoc for more such enriching educational sessions designed to keep you at the forefront of medical innovation.
See More Webinars @ Hidoc Webinars
1.
In a study, immune detection of oral cancers is linked to obesity.
2.
FDA approves rivanetin as the first-line treatment for lung cancer.
3.
Extended Maintenance with Imatinib Enhances Disease-Free Survival in High-Risk GIST.
4.
Regular physical activity before cancer diagnosis may lower progression and death risks
5.
Alternative Medicine for Breast Cancer: Study Raises Concern
1.
What is Red Cell Distribution Width and Why Should You Care?
2.
Mast Cell-Tumor Cell Interactions in OSCC: Genetic and microRNA Insights
3.
Targeted Therapy: Latest Advances, Learning Tools, Trials & Treatment Options Explained
4.
Hemophilia B and Gene Therapy: A New Chapter with Etranacogene Dezaparvovec
5.
AI-Powered Rehabilitation: A Game Changer for Hemophilia Management
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Efficient Management of First line ALK-rearranged NSCLC - Part IV
2.
Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I
5.
Navigating the Complexities of Ph Negative ALL - Part X
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation